vs
Side-by-side financial comparison of Chemours Co (CC) and Dexcom (DXCM). Click either name above to swap in a different company.
Chemours Co is the larger business by last-quarter revenue ($1.3B vs $1.3B, roughly 1.1× Dexcom). Dexcom runs the higher net margin — 21.2% vs -3.5%, a 24.8% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -2.1%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -1.2%).
The Chemours Company is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States. Chemours is the manufacturer of Teflon, the brand name of polytetrafluoroethylene (PTFE), known for its anti-stick properties. It also produces titanium dioxide and refrigerant gases.
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
CC vs DXCM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.3B |
| Net Profit | $-47.0M | $267.3M |
| Gross Margin | 11.7% | 62.9% |
| Operating Margin | — | 25.6% |
| Net Margin | -3.5% | 21.2% |
| Revenue YoY | -2.1% | 21.6% |
| Net Profit YoY | -261.5% | 153.6% |
| EPS (diluted) | $-0.32 | $0.67 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.3B | $1.3B | ||
| Q3 25 | $1.5B | $1.2B | ||
| Q2 25 | $1.6B | $1.2B | ||
| Q1 25 | $1.4B | $1.0B | ||
| Q4 24 | $1.4B | $1.1B | ||
| Q3 24 | $1.5B | $994.2M | ||
| Q2 24 | $1.6B | $1.0B |
| Q1 26 | — | $267.3M | ||
| Q4 25 | $-47.0M | $267.3M | ||
| Q3 25 | $46.0M | $283.8M | ||
| Q2 25 | $-380.0M | $179.8M | ||
| Q1 25 | $-5.0M | $105.4M | ||
| Q4 24 | $-13.0M | $151.7M | ||
| Q3 24 | $-32.0M | $134.6M | ||
| Q2 24 | $60.0M | $143.5M |
| Q1 26 | — | 62.9% | ||
| Q4 25 | 11.7% | 62.9% | ||
| Q3 25 | 15.6% | 60.5% | ||
| Q2 25 | 17.2% | 59.5% | ||
| Q1 25 | 17.3% | 56.9% | ||
| Q4 24 | 19.4% | 58.9% | ||
| Q3 24 | 19.0% | 59.7% | ||
| Q2 24 | 19.8% | 62.4% |
| Q1 26 | — | 25.6% | ||
| Q4 25 | — | 25.6% | ||
| Q3 25 | 2.5% | 20.1% | ||
| Q2 25 | -15.4% | 18.4% | ||
| Q1 25 | — | 12.9% | ||
| Q4 24 | -0.1% | 17.0% | ||
| Q3 24 | -2.1% | 15.3% | ||
| Q2 24 | 4.4% | 15.7% |
| Q1 26 | — | 21.2% | ||
| Q4 25 | -3.5% | 21.2% | ||
| Q3 25 | 3.1% | 23.5% | ||
| Q2 25 | -23.5% | 15.5% | ||
| Q1 25 | -0.4% | 10.2% | ||
| Q4 24 | -1.0% | 13.6% | ||
| Q3 24 | -2.1% | 13.5% | ||
| Q2 24 | 3.9% | 14.3% |
| Q1 26 | — | $0.67 | ||
| Q4 25 | $-0.32 | $0.67 | ||
| Q3 25 | $0.31 | $0.70 | ||
| Q2 25 | $-2.53 | $0.45 | ||
| Q1 25 | $-0.03 | $0.27 | ||
| Q4 24 | $-0.07 | $0.37 | ||
| Q3 24 | $-0.22 | $0.34 | ||
| Q2 24 | $0.39 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $670.0M | $917.7M |
| Total DebtLower is stronger | $4.1B | — |
| Stockholders' EquityBook value | $250.0M | $2.7B |
| Total Assets | $7.4B | $6.3B |
| Debt / EquityLower = less leverage | 16.40× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $917.7M | ||
| Q4 25 | $670.0M | $917.7M | ||
| Q3 25 | $613.0M | $1.8B | ||
| Q2 25 | $502.0M | $1.2B | ||
| Q1 25 | $464.0M | $904.9M | ||
| Q4 24 | $713.0M | $606.1M | ||
| Q3 24 | $596.0M | $621.2M | ||
| Q2 24 | $604.0M | $939.2M |
| Q1 26 | — | — | ||
| Q4 25 | $4.1B | — | ||
| Q3 25 | $4.1B | — | ||
| Q2 25 | $4.1B | — | ||
| Q1 25 | $4.1B | — | ||
| Q4 24 | $4.1B | — | ||
| Q3 24 | $4.0B | — | ||
| Q2 24 | $4.0B | — |
| Q1 26 | — | $2.7B | ||
| Q4 25 | $250.0M | $2.7B | ||
| Q3 25 | $274.0M | $2.7B | ||
| Q2 25 | $228.0M | $2.6B | ||
| Q1 25 | $566.0M | $2.3B | ||
| Q4 24 | $571.0M | $2.1B | ||
| Q3 24 | $643.0M | $2.0B | ||
| Q2 24 | $714.0M | $2.4B |
| Q1 26 | — | $6.3B | ||
| Q4 25 | $7.4B | $6.3B | ||
| Q3 25 | $7.5B | $7.5B | ||
| Q2 25 | $7.5B | $7.3B | ||
| Q1 25 | $7.4B | $6.8B | ||
| Q4 24 | $7.5B | $6.5B | ||
| Q3 24 | $7.5B | $6.4B | ||
| Q2 24 | $7.2B | $6.8B |
| Q1 26 | — | — | ||
| Q4 25 | 16.40× | — | ||
| Q3 25 | 14.96× | — | ||
| Q2 25 | 17.99× | — | ||
| Q1 25 | 7.18× | — | ||
| Q4 24 | 7.11× | — | ||
| Q3 24 | 6.20× | — | ||
| Q2 24 | 5.53× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $137.0M | — |
| Free Cash FlowOCF − Capex | $92.0M | — |
| FCF MarginFCF / Revenue | 6.9% | — |
| Capex IntensityCapex / Revenue | 3.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $51.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $137.0M | $294.0M | ||
| Q3 25 | $146.0M | $659.9M | ||
| Q2 25 | $93.0M | $303.0M | ||
| Q1 25 | $-112.0M | $183.8M | ||
| Q4 24 | $138.0M | $301.4M | ||
| Q3 24 | $139.0M | $199.5M | ||
| Q2 24 | $-620.0M | $279.4M |
| Q1 26 | — | — | ||
| Q4 25 | $92.0M | $192.1M | ||
| Q3 25 | $105.0M | $579.4M | ||
| Q2 25 | $50.0M | $208.9M | ||
| Q1 25 | $-196.0M | $96.8M | ||
| Q4 24 | $29.0M | $176.8M | ||
| Q3 24 | $63.0M | $88.3M | ||
| Q2 24 | $-693.0M | $213.3M |
| Q1 26 | — | — | ||
| Q4 25 | 6.9% | 15.3% | ||
| Q3 25 | 7.0% | 47.9% | ||
| Q2 25 | 3.1% | 18.1% | ||
| Q1 25 | -14.3% | 9.3% | ||
| Q4 24 | 2.1% | 15.9% | ||
| Q3 24 | 4.2% | 8.9% | ||
| Q2 24 | -44.6% | 21.2% |
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | 8.1% | ||
| Q3 25 | 2.7% | 6.7% | ||
| Q2 25 | 2.7% | 8.1% | ||
| Q1 25 | 6.1% | 8.4% | ||
| Q4 24 | 8.0% | 11.2% | ||
| Q3 24 | 5.0% | 11.2% | ||
| Q2 24 | 4.7% | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.10× | ||
| Q3 25 | 3.17× | 2.33× | ||
| Q2 25 | — | 1.69× | ||
| Q1 25 | — | 1.74× | ||
| Q4 24 | — | 1.99× | ||
| Q3 24 | — | 1.48× | ||
| Q2 24 | -10.33× | 1.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CC
| Titanium Technologies | $563.0M | 42% |
| Thermal And Specialized Solutions | $443.0M | 33% |
| Advanced Performance Materials | $312.0M | 23% |
| Other Non-Reportable Segment | $12.0M | 1% |
DXCM
Segment breakdown not available.
